Inhibitory Effect of Intravitreal Injection of Bevacizumab on Nerve Growth Factor

REFERENCES

• Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci. 2001;114:853–865.
   PubMed Web of Science ®Google Scholar
• Sun Y, Jin K, Xie L et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111:1843–1851.
   PubMed Web of Science ®Google Scholar
• Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987;237:1154–1162.
   PubMed Web of Science ®Google Scholar
• Calza L, Giardino L, Giuliani A, Aloe L, Levi-Montalcini R. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci USA. 2001;98:4160–4165.
   PubMed Web of Science ®Google Scholar
• Hansen-Algenstaedt N, Algenstaedt P, Schaefer C et al. Neural driven angiogenesis by overexpression of nerve growth factor. Histochem Cell Biol. 2006;125:637–649.
   PubMed Web of Science ®Google Scholar
• Weinstein BM. Vessels and nerves: marching to the same tune. Cell. 2005;120:299–302.
   PubMed Web of Science ®Google Scholar
• Brouzas D, Charakidas A, Moschos M, Koutsandrea C, Apostolopoulos M, Baltatzis S. Bevacizumab (Avastin) for the management of anterior chamber neovascularization and neovascular glaucoma. Clin Ophthalmol. 2009;3:685–688.
   PubMedGoogle Scholar
• Tao Y, Jonas JB. Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant exudative age-related macular degeneration. J Ocul Pharmacol Ther. 2010;26:207–212.
   PubMed Web of Science ®Google Scholar
• Ameri H, Chader GJ, Kim JG, Sadda SR, Rao NA, Humayun MS. The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci. 2007;48:5708–5715.
   PubMed Web of Science ®Google Scholar
• Shahar J, Avery RL, Heilweil G et al. Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina (Philadelphia, Pa). 2006;26:262–269.
   PubMed Web of Science ®Google Scholar
• Heiduschka P, Fietz H, Hofmeister S et al.; Tübingen Bevacizumab Study Group. Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci. 2007;48:2814–2823.
   PubMed Web of Science ®Google Scholar
• Dib E, Maia M, Longo-Maugeri IM et al. Subretinal bevacizumab detection after intravitreous injection in rabbits. Invest Ophthalmol Vis Sci. 2008;49:1097–1100.
   PubMed Web of Science ®Google Scholar
• Manzano RP, Peyman GA, Khan P, Kivilcim M. Testing intravitreal toxicity of bevacizumab (Avastin). Retina (Philadelphia, Pa). 2006;26:257–261.
   PubMed Web of Science ®Google Scholar
• Feiner L, Barr EE, Shui YB, Holekamp NM, Brantley MA Jr. Safety of intravitreal injection of bevacizumab in rabbit eyes. Retina (Philadelphia, Pa). 2006;26:882–888.
   PubMed Web of Science ®Google Scholar
• Bakri SJ, Cameron JD, McCannel CA, Pulido JS, Marler RJ. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model. Am J Ophthalmol. 2006;142:162–164.
   PubMed Web of Science ®Google Scholar
• Inan UU, Avci B, Kusbeci T, Kaderli B, Avci R, Temel SG. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes. Invest Ophthalmol Vis Sci. 2007;48:1773–1781.
   PubMed Web of Science ®Google Scholar
• Avci B, Avci R, Inan UU, Kaderli B. Comparative evaluation of apoptotic activity in photoreceptor cells after intravitreal injection of bevacizumab and pegaptanib sodium in rabbits. Invest Ophthalmol Vis Sci. 2009;50:3438–3446.
   PubMed Web of Science ®Google Scholar
• Saint-Geniez M, Maharaj AS, Walshe TE et al. Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS ONE. 2008;3:e3554.
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–2342.
   PubMed Web of Science ®Google Scholar
• Duan WR, Garner DS, Williams SD, Funckes-Shippy CL, Spath IS, Blomme EA. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol. 2003;199:221–228.
   PubMed Web of Science ®Google Scholar
• Sung CH, Chuang JZ. The cell biology of vision. J Cell Biol. 2010;190:953–963.
   Google Scholar
• Kim JH, Kim C, Kim JH et al. Absence of intravitreal bevacizumab-induced neuronal toxicity in the retina. Neurotoxicology. 2008;29:1131–1135.
   PubMed Web of Science ®Google Scholar
• Lu F, Adelman RA. Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization? Graefes Arch Clin Exp Ophthalmol. 2009;247:171–177.
   PubMed Web of Science ®Google Scholar
• Lin YS, Nguyen C, Mendoza JL et al. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. J Pharmacol Exp Ther. 1999;288:371–378.
   PubMed Web of Science ®Google Scholar
• Fuh G, Wu P, Liang WC et al. Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab. J Biol Chem. 2006;281:6625–6631.
   PubMed Web of Science ®Google Scholar
• Lambiase A, Aloe L. Nerve growth factor delays retinal degeneration in C3H mice. Graefes Arch Clin Exp Ophthalmol. 1996;234 Suppl 1:S96–100.
   PubMed Web of Science ®Google Scholar
• Lenzi L, Coassin M, Lambiase A, Bonini S, Amendola T, Aloe L. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res. 2005;45:1491–1500.
   PubMed Web of Science ®Google Scholar
• Sun XD, Zhang X, Xu X, Yu Z, Chen RJ. [Neuroprotection of nerve growth factor in experiment retinal detachment]. Zhonghua Yan Ke Za Zhi. 2003;39:303–307.
   PubMedGoogle Scholar
• Sun X, Xu X, Wang F et al. Effects of nerve growth factor for retinal cell survival in experimental retinal detachment. Curr Eye Res. 2007;32:765–772.
   PubMed Web of Science ®Google Scholar
• Nguyen TL, Kim CK, Cho JH, Lee KH, Ahn JY. Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR [corrected]. Exp Mol Med. 2010;42:583–595.
   PubMed Web of Science ®Google Scholar
• Salis MB, Graiani G, Desortes E, Caldwell RB, Madeddu P, Emanueli C. Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia. 2004;47:1055–1063.
   PubMed Web of Science ®Google Scholar
• Ali TK, Al-Gayyar MM, Matragoon S et al. Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury. Diabetologia. 2011;54:657–668.
   PubMed Web of Science ®Google Scholar
• Lazarovici P, Marcinkiewicz C, Lelkes PI. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharm Des. 2006;12:2609–2622.
   PubMedGoogle Scholar
• Lazarovici P, Gazit A, Staniszewska I, Marcinkiewicz C, Lelkes PI. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane. Endothelium. 2006;13:51–59.
   PubMed Web of Science ®Google Scholar
• Kim EC, Lee WS, Kim MS. The inhibitory effects of bevacizumab eye drops on NGF expression and corneal wound healing in rats. Invest Ophthalmol Vis Sci. 2010;51:4569–4573.
   PubMed Web of Science ®Google Scholar
• Sornelli F, Lambiase A, Mantelli F, Aloe L. NGF and NGF-receptor expression of cultured immortalized human corneal endothelial cells. Mol Vis. 2010;16:1439–1447.
   PubMed Web of Science ®Google Scholar
• Julio-Pieper M, Lozada P, Tapia V et al. Nerve growth factor induces vascular endothelial growth factor expression in granulosa cells via a trkA receptor/mitogen-activated protein kinase-extracellularly regulated kinase 2-dependent pathway. J Clin Endocrinol Metab. 2009;94:3065–3071.
   Google Scholar
• Romon R, Adriaenssens E, Lagadec C, Germain E, Hondermarck H, Le Bourhis X. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer. 2010;9:157.
   PubMed Web of Science ®Google Scholar
• Nico B, Mangieri D, De Luca A et al. Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse. Neuroscience. 2009;161:1057–1066.
   PubMed Web of Science ®Google Scholar
• Lin G, Shindel AW, Fandel TM, Bella AJ, Lin CS, Lue TF. Neurotrophic effects of brain-derived neurotrophic factor and vascular endothelial growth factor in major pelvic ganglia of young and aged rats. BJU Int. 2010;105:114–120.
   PubMed Web of Science ®Google Scholar
• Sanchez A, Wadhwani S, Grammas P. Multiple neurotrophic effects of VEGF on cultured neurons. Neuropeptides. 2010;44:323–331.
   PubMed Web of Science ®Google Scholar
• Carmignoto G, Comelli MC, Candeo P et al. Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina. Exp Neurol. 1991;111:302–311.
   PubMed Web of Science ®Google Scholar
• Hallböök F, Bäckström A, Kullander K, Ebendal T, Carri NG. Expression of neurotrophins and Trk receptors in the avian retina. The Journal of comparative neurology (J Comp Neurol). 1996;364:664–676.
   PubMed Web of Science ®Google Scholar
• Yu CQ, Zhang M, Matis KI, Kim C, Rosenblatt MI. Vascular endothelial growth factor mediates corneal nerve repair. Invest Ophthalmol Vis Sci. 2008;49:3870–3878.
   PubMed Web of Science ®Google Scholar
• Spitzer MS, Yoeruek E, Sierra A et al. Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells. Graefes Arch Clin Exp Ophthalmol. 2007;245:1837–1842.
   PubMed Web of Science ®Google Scholar
• Luthra S, Narayanan R, Marques LE et al. Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells. Retina (Philadelphia, Pa). 2006;26:512–518.
   PubMed Web of Science ®Google Scholar